Latest Asx News

Medallion Metals and IGO Limited have agreed to extend the deadline for completing the Forrestania Nickel Operation acquisition, allowing more time to meet key conditions and secure environmental approvals.

Mayne Pharma has rejected Cosette Pharmaceuticals’ notice to terminate their merger agreement, citing Cosette’s failure to meet obligations that led to regulatory approval issues. The dispute raises fresh uncertainty over the proposed acquisition’s future.

Orion Minerals has responded to an ASX price query following a recent uptick in its share price, confirming no undisclosed material information exists while highlighting ongoing financing talks with Glencore.

Torque Metals has raised $15 million in a placement led by top-tier global investors, setting the stage for an aggressive drilling campaign at its Paris Gold Project in Western Australia.

High-Tech Metals Limited is advancing near-term gold production at its Mt Fisher and Mt Eureka projects, leveraging historical stockpiles and high-grade resources while pursuing aggressive exploration to expand its resource base.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

LTR Pharma has received regulatory clearance from the Therapeutic Goods Administration to commence its Phase II clinical trial of SPONTAN, focusing on men aged 65 and over. Patient recruitment is set to begin early next year, aiming to address a key gap in erectile dysfunction treatment.

Astral Resources has successfully raised A$65 million through a strongly supported placement to advance its Mandilla Gold Project and accelerate exploration across its Western Australian gold assets.

Sentinel Metals has completed a detailed geophysical and structural study at its Columbia Gold Project, revealing promising deep feeder zones and strike extensions. A maiden 5,000m diamond drill program is set to test these new targets, potentially expanding the project's resource base.

4DMedical secures a key clinical adoption milestone as the University of Miami begins using its CT – VQ™ respiratory imaging technology, following Stanford’s lead. Meanwhile, Lahey Hospital inks a two-year deal for IQ-UIP™, underscoring growing traction in US academic medical centers.

Aurora Labs has secured its first $250,000 order for AU4 propulsion engines from Sovereign Propulsion Systems, marking a key step in its commercialisation strategy targeting unmanned aerial vehicles and defence markets.

Charter Hall Group is set to execute a capital reallocation of 42.28 cents per security, shifting capital from its limited company shares to property trust units without cash exchanges. This move, approved by securityholders, carries important tax implications for investors.